OBJECTIVE: Disparities in anal cancer incidence among Hawaii's HIV-infected minority population is an emerging health concern. Although anal cytology/anoscopy are effective anal cancer screening tools, social barriers exist that prevent individuals from seeking appropriate care. DESIGN: Community based participatory research (CBPR) principles were applied to develop resources, including testing a self-obtained anal specimen procedure, to increase anal cancer screening among Hawaii's underserved/ minority populations. METHODS: A team of community members, academic researchers, and health care providers developed culturally-sensitive educational/recruitment materials regarding anal cancer risk targeting underserved/minority HIV-infected individuals. Self- and health care provider (HCP)-obtained anal cancer screening specimens were reviewed for cytology and tested for human papillomavirus DNA. A follow-up evaluation elicited feedback on attitudes and experiences. RESULTS: Community discussion sessions identified key messages about anal cancer, anal cancer screening, and HPV infection for materials and were used, that successfully recruited 46 individuals (38 males/8 females; 9 Native Hawaiians/Pacific Islanders/Asians, 2 Blacks, 6 Hispanics, 6 American Indian/Alaskan Natives, 23 Whites). Concordance in cytology results between self- and HCP-obtained specimens was moderated (kappa=0.37) with the perception that the self-obtained specimen procedure was private (93%), safe (100%), and easy to manage (100%); and a majority (92%) willing to use the self-obtained method again. CONCLUSIONS: CBPR was a practical approach in engaging Hawaii's HIV-infected minority participation in anal cancer screening research. Community outreach and recruitment efforts suggested that self-obtained screening specimens could be an acceptable and effective means to reach Hawaii's HIV-infected ethnic minorities.
OBJECTIVE: Disparities in anal cancer incidence among Hawaii's HIV-infected minority population is an emerging health concern. Although anal cytology/anoscopy are effective anal cancer screening tools, social barriers exist that prevent individuals from seeking appropriate care. DESIGN: Community based participatory research (CBPR) principles were applied to develop resources, including testing a self-obtained anal specimen procedure, to increase anal cancer screening among Hawaii's underserved/ minority populations. METHODS: A team of community members, academic researchers, and health care providers developed culturally-sensitive educational/recruitment materials regarding anal cancer risk targeting underserved/minority HIV-infected individuals. Self- and health care provider (HCP)-obtained anal cancer screening specimens were reviewed for cytology and tested for human papillomavirus DNA. A follow-up evaluation elicited feedback on attitudes and experiences. RESULTS: Community discussion sessions identified key messages about anal cancer, anal cancer screening, and HPV infection for materials and were used, that successfully recruited 46 individuals (38 males/8 females; 9 Native Hawaiians/Pacific Islanders/Asians, 2 Blacks, 6 Hispanics, 6 American Indian/Alaskan Natives, 23 Whites). Concordance in cytology results between self- and HCP-obtained specimens was moderated (kappa=0.37) with the perception that the self-obtained specimen procedure was private (93%), safe (100%), and easy to manage (100%); and a majority (92%) willing to use the self-obtained method again. CONCLUSIONS: CBPR was a practical approach in engaging Hawaii's HIV-infected minority participation in anal cancer screening research. Community outreach and recruitment efforts suggested that self-obtained screening specimens could be an acceptable and effective means to reach Hawaii's HIV-infected ethnic minorities.
Entities:
Keywords:
Anal dysplasia; Anal neoplasia; Human immunodeficiency virus; Human papillomavirus
Authors: P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple Journal: J Clin Microbiol Date: 2000-01 Impact factor: 5.948
Authors: Nancy F Crum-Cianflone; Katherine Huppler Hullsiek; Vincent C Marconi; Anuradha Ganesan; Amy Weintrob; Robert V Barthel; Brian K Agan Journal: AIDS Date: 2010-02-20 Impact factor: 4.177
Authors: Ross D Cranston; Teresa M Darragh; Elizabeth A Holly; Naomi Jay; J Michael Berry; Maria Da Costa; Jimmy T Efird; Joel M Palefsky Journal: J Acquir Immune Defic Syndr Date: 2004-08-01 Impact factor: 3.731
Authors: Anna R Giuliano; Guillermo Tortolero-Luna; Elena Ferrer; Ann N Burchell; Silvia de Sanjose; Susanne Kruger Kjaer; Nubia Muñoz; Mark Schiffman; F Xavier Bosch Journal: Vaccine Date: 2008-08-19 Impact factor: 3.641
Authors: Thomas M Lampinen; Mary Lou Miller; Keith Chan; Aranka Anema; Dirk van Niekerk; Arn J Schilder; Robert Taylor; Robert S Hogg Journal: Cytojournal Date: 2006-03-20 Impact factor: 2.091
Authors: Lana Sue I Ka'opua; Kevin Cassel; Bruce Shiramizu; Rebecca L Stotzer; Andrew Robles; Cathy Kapua; Malulani Orton; Cris Milne; Maddalynn Sesepasara Journal: Health Promot Pract Date: 2015-12-02
Authors: Alan G Nyitray; Vanessa Schick; Michael D Swartz; Anna R Giuliano; Maria E Fernandez; Ashish A Deshmukh; Timothy J Ridolfi; Christopher Ajala; Bridgett Brzezinski; Micaela Sandoval; Belinda Nedjai; Jennifer S Smith; Elizabeth Y Chiao Journal: BMJ Open Date: 2021-06-29 Impact factor: 2.692